Naproxen 375 MG Oral Tablet — RxCUI 198012
RxNorm drug concept · Semantic clinical drug
RxCUI 198012
Semantic clinical drug · SCD
● Current RxNorm concept 81 FDA products
274 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198012
Official nameNaproxen 375 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped81
Package NDCs mapped274
Reported Medicaid activity (SDUD)2,444,449 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Naproxen: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- They're very similar — naproxen sodium is just the salt form of naproxen, and it dissolves in water more quickly. That means your body absorbs naproxen sodium a bit faster, so it t...
- What's the difference between naproxen and naproxen sodium — are they the same thing?
- You can take it either way, but taking it with food, milk, or a full glass of water is a good idea because it helps protect your stomach. Naproxen can irritate the lining of your s...
- Can I take naproxen on an empty stomach, or do I need to eat first?
🕸️ Concept Web — How Naproxen 375 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Naproxen 375 MG Oral Tablet
RxCUI 198012 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Naproxen
7258IN
-
Naproxen
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Naproxen Oral Tablet
373005SCDF -
Naproxen Oral Product
1157517SCDG -
Naproxen Pill
1157518SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Naproxen Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Naproxen 375 MG
316327SCDC
-
Naproxen 375 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Naproxen 375 MG
SCDC · 316327 -
Naproxen Oral Tablet
SCDF · 373005 -
Naproxen Oral Product
SCDG · 1157517 -
Naproxen Pill
SCDG · 1157518
📦 FDA Products & Package NDCs
81 products · 274 package NDCs
274 package NDCs map to RxCUI 198012 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 85766-0105-10 | 10 TABLET in 1 BOTTLE (85766-105-10) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0105-14 | 14 TABLET in 1 BOTTLE (85766-105-14) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0105-20 | 20 TABLET in 1 BOTTLE (85766-105-20) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0105-30 | 30 TABLET in 1 BOTTLE (85766-105-30) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0105-60 | 60 TABLET in 1 BOTTLE (85766-105-60) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0105-90 | 90 TABLET in 1 BOTTLE (85766-105-90) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-00 | 1000 TABLET in 1 BOTTLE (85766-106-00) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-01 | 100 TABLET in 1 BOTTLE (85766-106-01) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-05 | 500 TABLET in 1 BOTTLE (85766-106-05) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-10 | 10 TABLET in 1 BOTTLE (85766-106-10) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-14 | 14 TABLET in 1 BOTTLE (85766-106-14) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-20 | 20 TABLET in 1 BOTTLE (85766-106-20) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-30 | 30 TABLET in 1 BOTTLE (85766-106-30) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-60 | 60 TABLET in 1 BOTTLE (85766-106-60) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0106-90 | 90 TABLET in 1 BOTTLE (85766-106-90) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-00 | 1000 TABLET in 1 BOTTLE (85766-107-00) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-01 | 100 TABLET in 1 BOTTLE (85766-107-01) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-05 | 500 TABLET in 1 BOTTLE (85766-107-05) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-10 | 10 TABLET in 1 BOTTLE (85766-107-10) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-14 | 14 TABLET in 1 BOTTLE (85766-107-14) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-20 | 20 TABLET in 1 BOTTLE (85766-107-20) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-30 | 30 TABLET in 1 BOTTLE (85766-107-30) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-60 | 60 TABLET in 1 BOTTLE (85766-107-60) | Naproxen | Sportpharm LLC | 2025-10-15 |
| 85766-0107-90 | 90 TABLET in 1 BOTTLE (85766-107-90) | Naproxen | Sportpharm LLC | 2025-10-15 |
Observed labelers:
Bryant Ranch Prepack (36) ·
Sportpharm LLC (27) ·
Asclemed USA, Inc. (20) ·
MARKSANS PHARMA LIMITED (15) ·
A-S Medication Solutions (14) ·
Aphena Pharma Solutions - Tennessee, LLC (13)
· +25 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.